APA (7th ed.) Citation

Senent, Y., Fresquet, V., Jiménez, V., Valencia, K., Exposito, F., Martín-Úriz, P. S., . . . Sanmamed, M. F. (2025). Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors. Molecular Cancer, 24(1), 1. https://doi.org/10.1186/s12943-025-02352-4

Chicago Style (17th ed.) Citation

Senent, Yaiza, et al. "Co-targeting of Epigenetic Regulators and BCL-XL Improves Efficacy of Immune Checkpoint Blockade Therapy in Multiple Solid Tumors." Molecular Cancer 24, no. 1 (2025): 1. https://doi.org/10.1186/s12943-025-02352-4.

MLA (9th ed.) Citation

Senent, Yaiza, et al. "Co-targeting of Epigenetic Regulators and BCL-XL Improves Efficacy of Immune Checkpoint Blockade Therapy in Multiple Solid Tumors." Molecular Cancer, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12943-025-02352-4.